295 related articles for article (PubMed ID: 34582457)
1. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P
PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457
[TBL] [Abstract][Full Text] [Related]
2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
[TBL] [Abstract][Full Text] [Related]
3. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
D'Souza G; Springer G; Gustafson D; Kassaye S; Alcaide ML; Ramirez C; Sharma A; Palella FJ; Tien PC; Detels R; Kempf MC; Lahiri CD; Rinaldo CR; French AL; Margolick JB; Adimora AA
HIV Res Clin Pract; 2020 Oct; 21(5):130-139. PubMed ID: 33211636
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting.
Weng CH; Butt WWW; Brooks MB; Clarke C; Jenkins HE; Holland SD; Chiang SS
PLoS One; 2021; 16(12):e0249980. PubMed ID: 34898635
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results.
Lan FY; Filler R; Mathew S; Buley J; Iliaki E; Bruno-Murtha LA; Osgood R; Christophi CA; Fernandez-Montero A; Kales SN
PLoS One; 2020; 15(6):e0235460. PubMed ID: 32589687
[TBL] [Abstract][Full Text] [Related]
7. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
8. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
[TBL] [Abstract][Full Text] [Related]
9. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
[TBL] [Abstract][Full Text] [Related]
11. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
13. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
14. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
[TBL] [Abstract][Full Text] [Related]
15. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
16. Covid-19 presentation among symptomatic healthcare workers in Ireland.
O'Sullivan G; Jacob S; Barrett PM; Gallagher J
Occup Med (Lond); 2021 Apr; 71(2):95-98. PubMed ID: 33585881
[TBL] [Abstract][Full Text] [Related]
17. Universal screening for SARS-CoV-2 infection: a rapid review.
Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
[TBL] [Abstract][Full Text] [Related]
18. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
19. Symptom Criteria for COVID-19 Testing of Heath Care Workers.
Clemency BM; Varughese R; Scheafer DK; Ludwig B; Welch JV; McCormack RF; Ma C; Nan N; Giambra T; Raab T
Acad Emerg Med; 2020 Jun; 27(6):469-474. PubMed ID: 32396670
[TBL] [Abstract][Full Text] [Related]
20. Neurological features and outcome in COVID-19: dementia can predict severe disease.
Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS
J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
